|
2.23 Contingent Liabilities not provided for and commitments:
(in Rupees)
|
| |
Nature of Contingent Liability
|
March 31, 2025
|
March 31, 2024
|
|
i. Unexpired guarantees issued on behalf of the company by Banks for which the Company has provided counter guarantee
|
NIL
|
NIL
|
|
ii. Bills discounted with banks which have not matured
|
Nil
|
Nil
|
|
iii. Corporate Guarantees issued by Company on behalf of others to Commercial Banks & Financial Institutions
|
Nil
|
Nil
|
|
iv. Collateral Securities offered to Banks for the limit Sanctioned to others
|
Nil
|
Nil
|
|
v. Legal Undertakings given to Customs Authorities for clearing the imports
|
Nil
|
Nil
|
|
vi. Claims against the company not acknowledged as debts
|
|
|
|
a. Excise
|
NIL
|
NIL
|
|
b. Sales Tax
|
NIL
|
NIL
|
|
c. Service Tax
|
Nil
|
Nil
|
|
d. Income Tax
|
NIL
|
NIL
|
|
e. Civil Proceedings
|
NIL
|
NIL
|
|
f. Company Law Matters
|
Unascertainable
|
Unascertainable
|
|
g. Criminal Proceedings
|
Unascertainable
|
Unascertainable
|
|
h. Others
|
Nil
|
Nil
|
|
vii. Estimated amounts of contracts remaining to be executed on Capital Account and not provided for
|
Nil
|
Nil
|
2.24 Operating Segments (Ind AS 108)
Operating segment is a component of an entity:
a. That engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity).
b. Whose operating results are regularly reviewed by the entity’s chief operating decision maker to make decision about resources to be allocated to the segments and assess its performance, and
c. For which discrete financial information is available.
The Company is engaged in engaged manufacturing and trading of medical products. As there are no separate reportable segments, Segment Reporting as per Ind AS -108, "Operating Segments” is not applicable.
2.25 Events After the Reporting Period (Ind AS 10)
Events after the reporting period are those events, favorable and unfavorable, that occur between the end of the reporting and the date when the financial statements are approved by the Board of Directors in case of a company, and, by the corresponding approving authority in case of any other entity for issue. Two types of events can be identified:
• Those that provide evidence of conditions that existed at the end of reporting period (adjusting events after the reporting period);
• Those that are indicative of conditions that arose after the reporting period (non-adjusting events after the reporting period).
An entity shall adjust the amounts recognized in its financial statements to reflect adjusting events after the reporting period.
There are no such events are identified during the reporting period. Hence Ind AS 10 Events After the Reporting Period is not applicable.
2.26 Construction Contracts (Ind AS 11)
Construction contract is a contract specifically negotiated for the construction of an asset or a combination of assets that are closely interrelated or interdependent in terms of their design, technology, and function or their ultimate purpose or use.
The company is engaged manufacturing and trading of medical products, hence Ind AS 11 "Construction Contract” is not applicable.
2.27 Income Taxes (Ind AS 12)
The Tax Expense for the period comprises of current and deferred tax.
• Current Tax:
Current Tax Assets and Liabilities are measured at the amount expected to be recovered from or paid to the Income tax authorities, based on tax rates and laws that are enacted at the Balance Sheet date.
• Deferred Tax:
Deferred tax liabilities are recognized for all timing differences. Deferred tax assets are recognized for deductible timing differences only to the extent that there is reasonable certainty that sufficient future taxable income will be available against which such deferred tax assets can be realized. In situations where the Company has unabsorbed depreciation or carry forward tax losses, all deferred tax assets are recognized only if there is virtual certainty supported by convincing evidence that they can be realized against future taxable profits.
At each reporting date, the Company re-assesses unrecognized deferred tax assets. It recognizes unrecognized deferred tax asset to the extent that it has become reasonably certain or virtually certain, as the case may be, that sufficient future taxable income will be available against which such deferred tax assets can be realized.
The carrying amount of deferred tax assets are reviewed at each reporting date. The Company writes-down the carrying amount of deferred tax asset to the extent that it is no longer reasonably certain or virtually certain, as the case may be, that sufficient future taxable income will be available against which deferred tax asset can be realized. Any such write-down is reversed to
the extent that it becomes reasonably certain or virtually certain, as the case may be, that sufficient future taxable income will be available.
2.28 Related party (Ind AS 24)
Disclosures are made on related party relationships, transactions and outstanding balances, including commitments. Related parties are identified by the Company in accordance with the requirements of Ind AS 24 and are disclosed in the Notes to Financial Statements.
Related party transactions are reflected in the notes to accounts forming part of financial statements.
Sangam Health Care Products Limited Notes To Accounts22. Related Party Disclosures (Ind AS 24)
Related Party disclosures required as per Accounting Standard (Ind AS-24) on "Related Party disclosures "issued by the Institute of Chartered Accountants of India, are as below:
23. Consolidated and Separate Financial Statement (Ind AS 27)
The company has no subsidiary companies for the current reporting period. Hence consolidate and separate financial statement are not applicable.
24. Investments in Associates (Ind AS 28)
The company has not made any investments in any of its associates during the reporting period. This accounting standard has no financial impact on the financial statements for the current reporting period.
25. Interest in Joint Ventures (Ind AS 31)
The company has no interest in any Joint ventures. This accounting standard has no financial impact on the financial statements for the current reporting period.
26. Earnings Per Share (Ind AS 33):
a) Basic Earnings Per Share for (continued operations) there are no discontinued operations hence, EPS is presented for continued operations only.
27. Derivative instruments and un-hedged foreign currency exposure:
a) There are no outstanding derivative contracts as at March 31, 2025 and March 31, 2024.
b) Particulars of Un-hedged foreign currency exposure is: Nil
28. Loan Funds:
Secured Loans
29. Confirmation of Balances:
Confirmation letters have been issued by the company to Trade Receivables, Trade Payables, Advances to suppliers and others advances requesting that the confirming party responds to the company only if the confirming party disagrees with the balances provided in the request and however the company has not received any letters on disagreements.
34. Details of Loans given, Investments made, and Guarantee given covered Under Section 186(4) of the Companies Act, 2013.
The company has not extended any Corporate Guarantees in respect of loans availed by any company/firm as at March 31, 2025.
36. Dues to Micro Small and Medium Enterprises:
Disclosure required as per section 22 of the Micro, Small and Medium Enterprise Development Act, 2006 (MSMED Act.) as at 31.03.2025.
The information has been given in respect of such vendors to the extent they could be identified as micro and small enterprises on the basis of information available with company.
As per the information provided / submitted by the Company, there are no dues to Micro, Small and Medium Enterprises covered under (‘MSMED’ Act, 2006).
37. Non - Payment of Statutory dues:
The Company has certain delays in depositing statutory dues with the appropriate authorities. Although the amount is not material to the financial statements, this matter was of significance due to its regulatory implications and the nature of the obligation. The amount has been deducted but not paid to the regulatory authorities. The dues are given below:
38. Financial Risk Management
In course of its business, the company is exposed to certain financial risk such as market risk (Including currency risk and other price risks), credit risk and liquidity risk that could have significant influence on the company’s business and operational/financial performance. The Board of directors reviews and approves risk management framework and policies for managing these risks and monitor suitable mitigating actions taken by the management to minimize potential adverse effects and achieve greater predictability to earnings.
39. Credit Risk
Credit risk refers to the risk that the counterparty will default on its contractual obligations resulting in financial loss to the company. The company has adopted a policy of only dealing with creditworthy counterparties and obtaining sufficient collateral, where appropriate, a means of mitigating the risk of financial loss from defaults.
40. Liquidity risk
Liquidity risk refers to the risk that the company cannot meet its financial obligations. The objective of liquidity risk management is to maintain sufficient liquidity and ensure that funds are available for use as pre requirements. The Company’s exposure to liquidity risk is minimal as the promoters of the company is infusing the funds based on the requirements.
39. Amounts have been rounded off to nearest Rupee.
Schedules 2 to 39 form part of Balance Sheet and have been authenticated.
|